Figure 2
From: Opiorphin as a biomarker of orofacial conditions: a meta-analysis

JBI Critical Appraisal Tools to assess risk of bias summary in (A) case–control studies; (B) quasi-experimental studies; and (C) randomized clinical trials.
From: Opiorphin as a biomarker of orofacial conditions: a meta-analysis

JBI Critical Appraisal Tools to assess risk of bias summary in (A) case–control studies; (B) quasi-experimental studies; and (C) randomized clinical trials.